Published in Br J Haematol on May 01, 1969
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (1998) 18.36
Mediating mechanisms in a school-based drug prevention program: first-year effects of the Midwestern Prevention Project. Health Psychol (1991) 5.85
MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet (1999) 5.61
Computerized method of visual acuity testing: adaptation of the amblyopia treatment study visual acuity testing protocol. Am J Ophthalmol (2001) 5.37
A multicommunity trial for primary prevention of adolescent drug abuse. Effects on drug use prevalence. JAMA (1989) 5.31
The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol Chemother (1968) 4.75
Surveillance for asthma--United States, 1960-1995. MMWR CDC Surveill Summ (1998) 3.82
Measurement of adolescent smoking behavior: rationale and methods. J Behav Med (1984) 3.70
Saliva thiocyanate: a chemical indicator of cigarette smoking in adolescents. Am J Public Health (1981) 2.88
English language use as a risk factor for smoking initiation among Hispanic and Asian American adolescents: evidence for mediation by tobacco-related beliefs and social norms. Health Psychol (2000) 2.36
Recognition and treatment of intravascular coagulation. J Pediatr (1969) 2.35
Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med (1994) 2.13
Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group. N Engl J Med (1993) 2.09
Stability of blood in commonly used anticoagulants. Use of refrigerated blood for quality control of the Coulter Counter Model S. Am J Clin Pathol (1969) 2.07
Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada. Pediatr Pulmonol (1999) 2.05
Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group. N Engl J Med (1990) 2.05
Predicting binocular visual field sensitivity from monocular visual field results. Invest Ophthalmol Vis Sci (2000) 2.04
Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol (1993) 2.03
Reliability of self-report measures of drug use in prevention research: evaluation of the Project SMART questionnaire via the test-retest reliability matrix. J Drug Educ (1984) 1.97
Attrition in prevention research. J Behav Med (1985) 1.96
Smoking patterns of Asian-American youth in California and their relationship with acculturation. J Adolesc Health (1999) 1.90
Recognition and liking of tobacco and alcohol advertisements among adolescents: relationships with susceptibility to substance use. Prev Med (1995) 1.88
Incidence of visual field loss in 20,000 eyes and its relationship to driving performance. Arch Ophthalmol (1983) 1.88
Recent advances in the molecular pathology, cell biology and genetics of ciliopathies. J Med Genet (2008) 1.84
Optimum parameters for short-wavelength automated perimetry. J Glaucoma (1996) 1.84
Frequency doubling technology perimetry for detection of glaucomatous visual field loss. Am J Ophthalmol (2000) 1.83
Affective and social influences approaches to the prevention of multiple substance abuse among seventh grade students: results from project SMART. Prev Med (1988) 1.82
Prevention of cigarette smoking in seventh grade students. J Behav Med (1980) 1.78
Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group. Pediatr Pulmonol (1998) 1.73
Test-retest variability of frequency-doubling perimetry and conventional perimetry in glaucoma patients and normal subjects. Invest Ophthalmol Vis Sci (1999) 1.68
Studies on glycopeptides released by trypsin from intact human erythrocytes. Biochemistry (1967) 1.67
Incidence and prevalence of short wavelength automated perimetry deficits in ocular hypertensive patients. Am J Ophthalmol (2001) 1.66
Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group. Arch Ophthalmol (2000) 1.62
Identification of a conserved erythroid specific domain of histone acetylation across the alpha-globin gene cluster. Proc Natl Acad Sci U S A (2001) 1.57
DNA methylation is linked to deacetylation of histone H3, but not H4, on the imprinted genes Snrpn and U2af1-rs1. Mol Cell Biol (2001) 1.55
Prevention of cigarette smoking: three-year follow-up of an education program for youth. J Behav Med (1983) 1.52
Catheter-associated bacteremia with Nocardia nova with secondary pulmonary involvement. Pediatr Infect Dis J (1994) 1.51
Effects of a community-based prevention program on decreasing drug use in high-risk adolescents. Am J Public Health (1998) 1.50
The relationship of ovarian steroids, headache activity and menstrual distress: a pilot study with female migraineurs. Headache (1992) 1.50
Response properties of normal observers and patients during automated perimetry. Arch Ophthalmol (1989) 1.45
Mapping of a novel locus for achromatopsia (ACHM4) to 1p and identification of a germline mutation in the alpha subunit of cone transducin (GNAT2). J Med Genet (2002) 1.44
Regulation of the cytoplasmic accumulation of 5-methyltetrahydrofolate in MA104 cells is independent of folate receptor regulation. J Clin Invest (1989) 1.44
Variability components of standard automated perimetry and frequency-doubling technology perimetry. Invest Ophthalmol Vis Sci (2001) 1.42
Independent evaluation of the California Tobacco Education Program. Public Health Rep (1996) 1.40
Using parents as change agents for their children: a review. J Child Psychol Psychiatry (1973) 1.40
Acquired von Willebrand's syndrome in systemic lupus erythematosus. Blood (1968) 1.40
Anorexia nervosa: an overview. Am Fam Physician (1996) 1.39
Von Willebrand's disease: a comparative study of diagnostic tests. J Pediatr (1968) 1.39
Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J Immunol (1998) 1.39
Teaching family-centered perinatal care in family medicine, Part 2. Fam Med (1992) 1.37
Posthepatitic severe aplastic anemia--an indication for early bone marrow transplantation. Blood (1974) 1.36
Is acculturation a risk factor for early smoking initiation among Chinese American minors? A comparative perspective. Tob Control (1999) 1.35
Tailoring outdoor tobacco advertising to minorities in Los Angeles County. J Health Commun (2000) 1.34
Visual field damage in normal-tension and high-tension glaucoma. Am J Ophthalmol (1989) 1.34
Effects of target size and eccentricity on visual detection and resolution. Vision Res (1978) 1.33
Ethnic variation in peer influences on adolescent smoking. Nicotine Tob Res (2001) 1.33
Risky behavior in teens with cystic fibrosis or sickle cell disease: a multicenter study. Pediatrics (1998) 1.33
Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. Blood (1983) 1.32
Factors associated with poor outcomes in patients with lupus nephritis. Lupus (2005) 1.30
Psychosocial predictors of cigarette smoking onset by white, black, Hispanic, and Asian adolescents in Southern California. MMWR Morb Mortal Wkly Rep (1987) 1.30
Patterns of medical practice in cystic fibrosis: part II. Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Pediatr Pulmonol (1999) 1.29
Identification of adolescents at risk for smoking initiation: validation of a measure of susceptibility. Addict Behav (1997) 1.28
Senescent changes of the normal visual field: an age-old problem. Optom Vis Sci (2001) 1.25
dSIR2 and dHDAC6: two novel, inhibitor-resistant deacetylases in Drosophila melanogaster. Exp Cell Res (2001) 1.24
The Minnesota smoking prevention program: a seventh-grade health curriculum supplement. J Sch Health (1981) 1.24
Surveillance for dust storms and respiratory diseases in Washington State, 1991. Arch Environ Health (1994) 1.23
Functional decline in the elderly: evidence for direct and stress-buffering protective effects of social interactions and physical activity. Ann Behav Med (1997) 1.23
The consistency of peer and parent influences on tobacco, alcohol, and marijuana use among young adolescents. J Behav Med (1987) 1.23
Performance characteristics of the 3-D OSEM algorithm in the reconstruction of small animal PET images. Ordered-subsets expectation-maximixation. IEEE Trans Med Imaging (2000) 1.22
The effects of antenatal drug administration on aggregation of platelets of newborn infants. J Pediatr (1971) 1.20
Substance use among eighth-grade students who take care of themselves after school. Pediatrics (1989) 1.20
Visual function and driving safety. Arch Ophthalmol (1992) 1.20
Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion (1996) 1.19
A semiautomatic one-stage factor 8 assay with a commercially prepared standard. J Lab Clin Med (1967) 1.18
Meningococcemia associated with intravascular coagulation. Pediatrics (1967) 1.17
Blood coagulation in thyroid dysfunction. N Engl J Med (1965) 1.16
Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line. J Biol Chem (1998) 1.16
Compliance with oral drug therapy in patients with hematologic malignancy. J Clin Oncol (1987) 1.16
A new variant of dominant type II von Willebrand's disease with aberrant multimeric pattern of factor VIII-related antigen (type IID). Blood (1984) 1.15
Group-specific assays that distinguish between the four major types of mammalian phospholipase A2. Anal Biochem (1999) 1.15
Exposure to methyl tertiary-butyl ether from oxygenated gasoline in Stamford, Connecticut. Arch Environ Health (1995) 1.15
Hazard of smoking initiation by age among adolescents in Wuhan, China. Prev Med (2001) 1.15
Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial. Arch Ophthalmol (1994) 1.14
The television school and family smoking prevention and cessation project. 1. Theoretical basis and program development. Prev Med (1988) 1.14
Prevalence of oropharyngeal excreters of leukocyte-transforming agents among a human population. N Engl J Med (1973) 1.13
Comparison of central and peripheral visual field properties in the optic neuritis treatment trial. Am J Ophthalmol (1999) 1.13
Longitudinal comparison of temporal-modulation perimetry with white-on-white and blue-on-yellow perimetry in ocular hypertension and early glaucoma. J Opt Soc Am A Opt Image Sci Vis (1993) 1.13
The pharmacology and metabolism of the thiopurine drugs 6-mercaptopurine and azathioprine. Drug Metab Rev (1985) 1.12
Attitudes toward anti-tobacco policy among California youth: associations with smoking status, psychosocial variables and advocacy actions. Health Educ Res (1999) 1.12
Socioeconomic evaluation of a state-funded comprehensive hemophilia-care program. N Engl J Med (1982) 1.11
Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact on pregnancy outcome. Fertil Steril (1996) 1.11
Role of the Escherichia coli glnALG operon in regulation of ammonium transport. J Bacteriol (1986) 1.11
Suprathreshold static perimetry. Initial clinical trials with the Fieldmaster automated perimeter. Arch Ophthalmol (1979) 1.10
Intravenous use of gammaglobulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomy. J Pediatr (1983) 1.09
Mexican-American women in the labor force and lowered fertility. Am J Public Health (1976) 1.09
Continuation high schools: youth at risk for drug abuse. J Drug Educ (1995) 1.09